| pubmed-article:17937984 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17937984 | lifeskim:mentions | umls-concept:C0001975 | lld:lifeskim |
| pubmed-article:17937984 | lifeskim:mentions | umls-concept:C0002508 | lld:lifeskim |
| pubmed-article:17937984 | lifeskim:mentions | umls-concept:C0005050 | lld:lifeskim |
| pubmed-article:17937984 | lifeskim:mentions | umls-concept:C0031727 | lld:lifeskim |
| pubmed-article:17937984 | lifeskim:mentions | umls-concept:C1424448 | lld:lifeskim |
| pubmed-article:17937984 | lifeskim:mentions | umls-concept:C1155874 | lld:lifeskim |
| pubmed-article:17937984 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:17937984 | pubmed:issue | 23 | lld:pubmed |
| pubmed-article:17937984 | pubmed:dateCreated | 2007-11-6 | lld:pubmed |
| pubmed-article:17937984 | pubmed:abstractText | A series of benzimidazole compounds containing pendant alcohol and amine moieties was found to be active against checkpoint kinase Chk2. These compounds were prepared to examine a potential hydrogen bond interaction with an active site residue and to investigate replacement of a biaryl linker with an aliphatic system in an effort to improve solubility. | lld:pubmed |
| pubmed-article:17937984 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17937984 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17937984 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17937984 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17937984 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17937984 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17937984 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17937984 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17937984 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17937984 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17937984 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:17937984 | pubmed:issn | 1464-3405 | lld:pubmed |
| pubmed-article:17937984 | pubmed:author | pubmed-author:KarlssonLarsL | lld:pubmed |
| pubmed-article:17937984 | pubmed:author | pubmed-author:BrunmarkAnder... | lld:pubmed |
| pubmed-article:17937984 | pubmed:author | pubmed-author:Breitenbucher... | lld:pubmed |
| pubmed-article:17937984 | pubmed:author | pubmed-author:AxeFrank UFU | lld:pubmed |
| pubmed-article:17937984 | pubmed:author | pubmed-author:NeffDanielle... | lld:pubmed |
| pubmed-article:17937984 | pubmed:author | pubmed-author:Lee-DutraAlic... | lld:pubmed |
| pubmed-article:17937984 | pubmed:author | pubmed-author:HackMichael... | lld:pubmed |
| pubmed-article:17937984 | pubmed:author | pubmed-author:BlevittJonath... | lld:pubmed |
| pubmed-article:17937984 | pubmed:author | pubmed-author:BumaJohnathan... | lld:pubmed |
| pubmed-article:17937984 | pubmed:author | pubmed-author:RynbergRaymon... | lld:pubmed |
| pubmed-article:17937984 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17937984 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17937984 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:17937984 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17937984 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17937984 | pubmed:pagination | 6467-71 | lld:pubmed |
| pubmed-article:17937984 | pubmed:dateRevised | 2011-11-2 | lld:pubmed |
| pubmed-article:17937984 | pubmed:meshHeading | pubmed-meshheading:17937984... | lld:pubmed |
| pubmed-article:17937984 | pubmed:meshHeading | pubmed-meshheading:17937984... | lld:pubmed |
| pubmed-article:17937984 | pubmed:meshHeading | pubmed-meshheading:17937984... | lld:pubmed |
| pubmed-article:17937984 | pubmed:meshHeading | pubmed-meshheading:17937984... | lld:pubmed |
| pubmed-article:17937984 | pubmed:meshHeading | pubmed-meshheading:17937984... | lld:pubmed |
| pubmed-article:17937984 | pubmed:meshHeading | pubmed-meshheading:17937984... | lld:pubmed |
| pubmed-article:17937984 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17937984 | pubmed:articleTitle | 2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2. | lld:pubmed |
| pubmed-article:17937984 | pubmed:affiliation | Johnson & Johnson Pharmaceutical Research & Development, L.L.C, 3210 Merryfield Row, San Diego, CA 92121, USA. dneff1@prdus.jnj.com | lld:pubmed |
| pubmed-article:17937984 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17937984 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:17937984 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17937984 | lld:pubmed |
